PROFOUND MEDICAL CORP reports a Return on Equity (ROE) of -65.08%.

What is PROF's dividend yield?

PROFOUND MEDICAL CORP offers a dividend yield of 0.00%.

What is PROF's Quality Score?

Our AI rates PROF's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy PROF?

Our AI Timing Score for PROF is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does PROF belong to?

PROFOUND MEDICAL CORP is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange

PROF (NASDAQ) Stock Analysis | PROFOUND MEDICAL CORP

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

PROF AI Analysis Summary

Our AI summary for PROF: PROFOUND MEDICAL CORP (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -65.08%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

PROF

PROFOUND MEDICAL CORP

US:NASDAQ STOCK Healthcare >> Medical Devices

USD 7.38

0.13 (1.79%) Day Change

Watchlist Portfolio Compare Chart

0.08

D/E

-65.1%

ROE

-52.7%

ROA

0.00%

Div Yield

PROFOUND MEDICAL CORP
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 7.38 Price 0.13 (1.79%) Day Change	NEWS SCORE: N/A

PROF, the overall quality is not good ( Quality = 23) but the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	7.38
PBV / Sector	4.42 / -101.57
Earning Per Share	-1.09

PE / Sector	N/A / 31.23
PEG or PE/Growth / Sector	N/A / 0.40
Average 1M Daily Value	0.88 M GREAT
Average 1W Daily Value	1.44 M GREAT

Timing Factors

85%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-207.06 / 20.50
NPM Average (%) / Sector	-311.58 / -15.37
NPM Change Average (%) / Sector	-15.51 / 7.34
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-52.65 / 39.11
ROA Average (%) / Sector	-44.46 / 5.58
ROA Change Average (%) / Sector	24.53 / 104.50 GREAT
ROE (%) / Sector	-65.08 / -166.42
ROE Average (%) / Sector	-60.63 / -16.93
ROE Change Average (%) / Sector	14.80 / -500.08 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

Registration Details

Analyze Date	2026-08-01 08:00:21
Symbol	PROF
Name	PROFOUND MEDICAL CORP
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	36.34 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	263.45 / 20,104.97

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5

Phone: 647 476 1350

Website: https://www.profoundmedical.com

Employees: 162

Sector: Healthcare >> Medical Devices

Description: Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.